#ExpertAnswers: Craig Emter, Robert Hamlin, Timothy Hacker, and Filip Konecny on Pressure-Volume Loops
Airdate: Wednesday, April 23, 2014 Season: 1 Episode: 4
Guests: Craig Emter, Robert Hamlin, Timothy A. Hacker, Filip Konecny
This episode of #ExpertAnswers features Craig Emter, Assistant Professor in the College of Veterinary Medicine at the University of Missouri, Robert Hamlin, Professor at Ohio State University and Scientific Director of QTest Labs, Timothy Hacker, Director of the Cardiovascular Physiology and Surgery Core Facility at the University of Wisconcin-Madison, and Filip Konecny Application Scientist and Surgical Trainer at Transonic. They are here to discuss how PV loops work in concert with other techniques permitting complete hemodynamic evaluation.
For more information or to watch the webinar, click here.
Associated Webinar: Hemodynamic Assessment: Pressure-Volume Loop Case Studies
#ExpertAnswers: Artur Federowoski on Cardiovascular Dysautonomia in Post-COVID-19
Artur Federowski explains CV dysautonomia as a specific sequalae of acute COVID-19 and guides the audience in the diagnostic work-up of PASC patients with suspected cardiovascular complications.
#ExpertAnswers: Phil Griffiths on Telemetry Studies
Phil Griffiths draws from his experience as a telemetry user to discuss some important considerations for designing telemetry studies.
#ExpertAnswers: Cole McLarty, Nick Glover, and Tim Hacker on Pressure-Volume Loops
Cole McLarty, Nick Glover and Dr. Timothy Hacker focus on Pressure-Volume Loop collection and data analysis for cardiovascular research.
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection and Management
Artur Fedorowski, MD, PhD, describes cardiovascular dysautonomia in COVID-19 and the diagnostics behind detecting Long COVID or Post-acute Sequalae of COVID-19.
APS Physiology in Disease Modeling and Drug Development Roundtable
Key opinion leaders in cardiovascular physiology and bioengineering discuss best practices and challenges when modeling cardiomyopathies and other cardiovascular diseases using stem cells, engineered tissues and other novel platforms.
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemetry Studies
Phil Griffiths, PhD, presents a summary of chronic cardiovascular telemetry studies and considerations for experimental design.